Pure Global

Impact of E-cigarette Nicotine Concentration on Compensation - Trial NCT05887947

Access comprehensive clinical trial information for NCT05887947 through Pure Global AI's free database. This phase not specified trial is sponsored by University of Kansas Medical Center and is currently Recruiting. The study focuses on Smoking Cessation. Target enrollment is 48 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.

Free Database
Powered by Pure Global AI
840K+ Trials
NCT05887947
Recruiting
other
Trial Details
ClinicalTrials.gov • NCT05887947
View on ClinicalTrials.gov
Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing
Impact of E-cigarette Nicotine Concentration on Compensation
Impact of E-cigarette Nicotine Concentration on Compensation, Cigarette Smoking, and Biomarkers of Exposure and Harm in Diverse Smokers

Study Focus

Smoking Cessation

Electronic Cigarette Nicotine Concentration Order 1.8% 5% 1.8%

Interventional

other

Sponsor & Location

University of Kansas Medical Center

Kansas City, United States of America

Timeline & Enrollment

N/A

Feb 20, 2023

Feb 20, 2025

48 participants

Primary Outcome

Total inhaled volume

Summary

The study will be the first to assess the impact of nicotine concentration on compensatory
 puffing (total inhaled volume), nicotine delivery, and switch patterns (percent exclusive EC,
 dual cig-EC, and cig only users) with an explicit focus on AA and White smokers.

ICD-10 Classifications

Mental and behavioural disorders due to use of tobacco withdrawal state
Tobacco use
Exposure to tobacco smoke
Toxic effect: Tobacco and nicotine
Mental and behavioural disorders due to use of tobacco

Data Source

ClinicalTrials.gov

NCT05887947

Non-Device Trial